Earnings Feed
Start Free
Home/Insiders/GROENHUYSEN WILHELMUS CM
GW
SEC Insider//CIK 0001264783

GROENHUYSEN WILHELMUS CM

CIK 00012647833 companiesYARDLEY, PA
SEC Profile

Transactions

50

Companies

3

Filings

8

CIK

0001264783

Recent Transactions

50 trades
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−1,925→ 0 total
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−962→ 0 total
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−962→ 0 total
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−5,000→ 0 total
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−962→ 0 total
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−2,133→ 0 total
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−962→ 0 total
  • Disposition to Issuer
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2025-05-21−3,566→ 0 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-06-28$12.24/sh+1,055→ 252,290 total
  • Award
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2024-06-06+75,000→ 75,000 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-06-05$22.82/sh+124,373→ 124,373 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2024-06-05$22.82/sh−124,373→ 95,000 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-03-04$16.01/sh−1,217→ 251,235 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-03-01$16.03/sh−2,107→ 252,452 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-02-28$16.14/sh−2,303→ 254,559 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-02-27$16.30/sh+47,034→ 256,862 total
  • Award
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2024-02-27$16.30/sh+71,920→ 71,920 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-12-31$12.69/sh+3→ 209,828 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-09-01$21.82/sh−294→ 209,825 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-06-30$35.28/sh+366→ 210,119 total
  • Award
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2023-06-08+53,500→ 53,500 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−20,415→ 209,753 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−1,692→ 230,168 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−3,528→ 231,860 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+3,936→ 235,388 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+48,050→ 231,452 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-02$75.28/sh−1,213→ 183,402 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-01$76.36/sh−2,164→ 184,615 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-02-28+21,653→ 186,779 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-02-28$76.97/sh+36,013→ 36,013 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-06$62.30/sh+102→ 165,126 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-09-02$79.04/sh−296→ 165,024 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-07-05$59.08/sh+218→ 165,320 total
  • Award
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2022-06-08+32,000→ 32,000 total
  • Gift
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-05-05+1,324→ 147,048 total
  • Gift
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-05-05−1,324→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-08$70.10/sh−2,923→ 165,102 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-04$70.41/sh−2,569→ 168,025 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+38,390→ 38,390 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03$74.50/sh−1,301→ 170,594 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03+21,921→ 171,895 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+7,664→ 7,664 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-01-06$63.82/sh+75→ 149,974 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-09-02$138.23/sh−181→ 149,899 total
  • Gift
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-08-10−320→ 1,324 total
  • Gift
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-08-10+320→ 145,724 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-07-06$137.12/sh+66→ 150,080 total
  • Award
    OptiNose, Inc.

    Stock Option (Right to Buy)

    2021-06-09+14,439→ 14,439 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-08$130.81/sh−3,004→ 153,684 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-04$137.55/sh−3,854→ 156,688 total

Companies

3

Recent Filings

8

Address

C/O OPTINOSE, INC. 777 TOWNSHIP LINE ROAD, SUITE 300

YARDLEY, PA, 19067

View on SEC.gov